These effects, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two help the principle of targeting ACKR3 as a unique way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-related Issues. It can even be legally marketed https://sandrac765rvy0.wikiconversation.com/user